Macular Edema: all 847 studies
Page 7 of 9. Open to participants first (56), then studies with results posted, then the rest; newest registration first within each.
- Noctura400 Treatment for Diabetic Retinopathy (CANDLE)TerminatedNCT02207712Not applicable
- Observation of Treatment Patterns With Lucentis in Approved IndicationsCompletedNCT02194803
- Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)Status unknownNCT02194634Phase 3
- A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DMECompletedNCT02193113Phase 1
- An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)CompletedNCT02188173
- A Study of Abicipar Pegol in Patients With Diabetic Macular EdemaCompletedNCT02186119Phase 2
- Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein OcclusionStatus unknownNCT02169648Not applicable
- Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard antiVEGF DosingWithdrawnNCT02127684Phase 2
- Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema.CompletedNCT02121197
- Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular EdemaCompletedNCT02096874Phase 4
- Relating Retinal Structural and Functional Parameters to Visual Acuity in Eyes Undergoing Treatment for Diabetic Macular EdemaCompletedNCT02088229
- Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the RetinaTerminatedNCT02088151Not applicable
- Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After PhacoemulsificationCompletedNCT02084576Phase 4
- Reading Center - Occurence of Diabetic Macular Edema in Patients With Diabetes Mellitus in Slovak RepublicStatus unknownNCT02063321
- Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular EdemaStatus unknownNCT02059772Phase 4
- Retinal Ganglion Cell Function After Intravitreous Ranibizumab in Patients With Diabetic Macular EdemaWithdrawnNCT02055911Phase 4
- The TIME-2 Study: A Phase 2 Study of AKB-9778, a Novel Tie-2 Activator, in Patients With Diabetic Macular EdemaCompletedNCT02050828Phase 2
- Efficacy and Safety Study to Evaluate Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular EdemaCompletedNCT02002403Phase 2
- Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or RanibizumabCompletedNCT02000102
- Iluvien Registry Safety StudyStatus unknownNCT01998412
- Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular ("Wet") Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME)CompletedNCT01997164Phase 1
- Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAGCompletedNCT01978015Phase 4
- Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular DiseasesStatus unknownNCT01975103Phase 2
- Ranibizumab Treatment for Retinal Vein OcclusionStatus unknownNCT01968616Not applicable
- Characterization of Eyes With Diabetic Macular Edema That Show Different Treatment Response to Intravitreal Anti-VEGF (CHARTRES)CompletedNCT01947881
- Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGFTerminatedNCT01946399Not applicable
- Dexamethasone-Implant for the Treatment of Macula Edema Due to Irvine Gass SyndromeCompletedNCT01945892
- Macular Edema Nepafenac vs. Difluprednate Uveitis TrialTerminatedNCT01939691Phase 4
- Identifying Patients With Unrecognized Treatable Diabetic Macular EdemaStatus unknownNCT01934920
- Comparison Between Treatment With Yellow Micropulse Laser and Green Conventional Laser in Diabetic Macular EdemaStatus unknownNCT01928654Not applicable
- Time to Treatment Utilizing a Tele-Retinal Referral System for wAMD and DME: A Pilot StudyCompletedNCT01899963
- Pilot Study of OCT Versus Fluorescein Angiography in DMECompletedNCT01876914
- TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular EdemaCompletedNCT01870440Phase 4
- NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein OcclusionsCompletedNCT01870427Phase 4
- Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF TherapyStatus unknownNCT01857544Phase 4
- Ranibizumab For Persistent Diabetic Macular Edema After BevacizumabStatus unknownNCT01845844Phase 1/2
- Uptake of Telemedicine System Trial in Rual CantonCompletedNCT01832077
- Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein OcclusionStatus unknownNCT01827722Phase 4
- Reduction of Foveal Sensitivity in Eyes With Diabetic Macular EdemaCompletedNCT01824862
- Intravitreal Injections of Ranibizumab With Deferred Laser Grid Laser Photocoagulation for Treatment of Diabetic Macular Edema With Visual ImpairmentCompletedNCT01823965Phase 2
- Combined Intravitreal Fasudil and Bevacizumab for Diabetic Macular EdemaCompletedNCT01823081Phase 3
- Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair VisionTerminatedNCT01795209Phase 4
- Use of Diagnostic Dye to Identify Areas of Leakeage,in the Retina, Prior to Receiving Focal Laser TreatmentCompletedNCT01792141
- Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal PhotographyStatus unknownNCT01790945
- Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular OedemaCompletedNCT01787669Phase 2
- PRevention of Macular EDema After Cataract SurgeryCompletedNCT01774474Phase 3
- Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF TherapyCompletedNCT01771081
- Comparison of Initial Treatment in With Laser Grid in Diabetic Macular Edema to Intra Vitreal Avastin InjectionsStatus unknownNCT01769599
- Dexamethasone-implant for the Treatment of RVOCompletedNCT01767545Phase 4
- Topcon Endpoint ManagementCompletedNCT01732614Not applicable
- Diabetic Retinopathy And the Myvisiontrack® (DRAMA) StudyCompletedNCT01728883
- Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular EdemaCompletedNCT01702441Phase 1/2
- A Pilot Study of the Effectiveness of Intra-operative Ozurdex® in Vitrectomy Surgery for Epiretinal MembranesStatus unknownNCT01701518Not applicable
- Effect of Intraoperative Dexamethasone Implant in Taut Posterior Hyaloid Removal in Diabetic Macular EdemaCompletedNCT01698788Not applicable
- Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular EdemaCompletedNCT01698749Not applicable
- Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic RetinopathyCompletedNCT01694212Not applicable
- DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO)CompletedNCT01662518Phase 1/2
- Treatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis)CompletedNCT01638858Not applicable
- Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME)Status unknownNCT01635790Phase 2/3
- Angiographie and OCT in Macula and Retinal DiseasesCompletedNCT01603823
- Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein OcclusionStatus unknownNCT01581151Not applicable
- Intravitreal Aflibercept Injection for Radiation RetinopathyCompletedNCT01579760Phase 1
- Safety and Efficacy of Triamcinolone Acetonide Combined With Laser, Bevacizumab Combined With Laser Versus Laser Alone for the Treatment of Diffuse Non-tractional Diabetic Macular EdemaCompletedNCT01572350Phase 3
- The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular OedemaCompletedNCT01564108Phase 2
- Comparison of Topical Ketorolac 0,4% Versus Placebo in Cataract SurgeryCompletedNCT01542190Phase 4
- A Long-Term Safety Study of OZURDEX® in Clinical PracticeCompletedNCT01539577
- Topical Dexamethasone - Cyclodextrin Microparticle Eye Drops for Diabetic Macular EdemaStatus unknownNCT01523314Phase 2/3
- Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema)CompletedNCT01512966Phase 3
- Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)CompletedNCT01512901Phase 2/3
- Vitrectomy Retinal OxygenationWithdrawnNCT01510691
- A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular EdemaCompletedNCT01506895Phase 2
- Morphological and Functional Evaluation of Irvine-Gass SyndromeCompletedNCT01504074
- Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular EdemaStatus unknownNCT01487629Phase 2
- Safety Study of ALG- 1001 to Treat Diabetic Macular EdemaWithdrawnNCT01482871Phase 1/2
- Autologous Plasmin and Fibrinolytic System in Diabetic RetinopathyStatus unknownNCT01478516Not applicable
- Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF TherapyCompletedNCT01472510Phase 2
- PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)CompletedNCT01445899Phase 2
- Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein OcclusionCompletedNCT01428388Not applicable
- Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA)CompletedNCT01411254Phase 2/3
- Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal MembraneTerminatedNCT01410201Not applicable
- Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract SurgeryCompletedNCT01395069Phase 4
- CME With Different Fluidic ParametersCompletedNCT01385852Phase 4
- Glycemic Control and Diabetic Macular EdemaCompletedNCT01358396
- Evaluation of the Effects of Selective Photocoagulation for the Treatment of Diabetic Macular EdemaCompletedNCT01355692Phase 2/3
- Intravitreal Bevacizumab and Triamcinolone in Diabetic Macular EdemaCompletedNCT01342159Not applicable
- Safety and Efficacy by Multiple Injection of KH902 in Patients With Diabetic Macular Edema (DME)CompletedNCT01324869Phase 1/2
- Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic RetinopathyCompletedNCT01319487Phase 2
- Observe the Effectiveness and Safety of Ranibizumab in Real Life SettingCompletedNCT01318941
- A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular EdemaCompletedNCT01315275Phase 4
- Quality of Life in Patients With Intermediate UveitisCompletedNCT01314469
- Functional and Morphologic Aspects of Intravitreal Triamcinolone for Uveitis-associated Cystoid Macular EdemaCompletedNCT01299129
- Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular OedemaCompletedNCT01298076Phase 2
- Ranibizumab "Treat and Extend" in Diabetic Macular EdmaCompletedNCT01297569Phase 4
- Trientine Hydrochloride for the Prevention of Macular Edema After Cataract Surgery in Patients With Type 2 Diabetes MellitusWithdrawnNCT01295073Phase 2
- Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract SurgeryCompletedNCT01284478Phase 2
- Ozurdex for Macular Edema Post Membrane PeelingCompletedNCT01273727Phase 2/3
- Changes in Ciliary Body Thickness in Patients With Diabetic Macular Edema After VitrectomyCompletedNCT01259609Not applicable
- Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial TreatmentCompletedNCT01257815Phase 4
- Ranibizumab as a Rescue Therapy for Diabetic Macular EdemaWithdrawnNCT01253694Phase 2
- Major and Macular Branched Retinal Venous OcclusionCompletedNCT01219205Not applicable